[Ergometric dose-effect study of bunitrolol (Stresson) in patients with coronary heart disease (author's transl)].

Abstract

20 patients with coronary heart disease and ergometrically provocable stenocardias and electrocardiographic signs of ischemia were tested ergometrically with two different dosages (5 mg:20 mg) of the beta-blocking agent bunitrolol (Stresson) in a double-blind-test. The results obtained are in accordance with literature: The greater the ergometric stress the more effective is Stresson and vice versa. For treatment of coronary heart disease can be considered: Low dosage of Stresson in patients with stenocardias and hypoxias in high-grade exercise, high dosage of Stresson in patients with stenocardias or ischemias in low-grade exercise or rest.

• Authors: H Böhm, B Höhm, B Ludwig, W Madl, F Werner
• Journal: Wiener medizinische Wochenschrift (1946) (Wien Med Wochenschr) Vol. 131 Issue 18 Pg. 457-61 (Sep 30 1981) ISSN: 0043-5341 [Print] Austria
• Vernacular Title: Ergometrische Dosis-Wirkungs-Studies mit Bunitrolol (Stresson) bei Patienten mit koronarer Herzkrankheit.
• PMID: 6117988 (Publication Type: Clinical Trial, English Abstract, Journal Article, Randomized Controlled Trial)

Chemical References

• Propanolamines

Topics

• Clinical Trials as Topic
• Coronary Disease (drug therapy)
• Dose-Response Relationship, Drug
• Double-Blind Method
• Female
• Hemodynamics (drug effects)
• Humans
• Male
• Middle Aged
• Myocardial Infarction (drug therapy)
• Physical Exertion
• Propanolamines (therapeutic use)